Accession Number : AD1040568


Title :   In House HSV PCR, Process Improvement and Cost Effectiveness Analysis


Descriptive Note : Conference Paper


Corporate Author : 59th Medical Wing San Antonio United States


Personal Author(s) : Carr,Nicholas R ; Weber,Zachary J ; Sutter,Deena E


Full Text : https://apps.dtic.mil/dtic/tr/fulltext/u2/1040568.pdf


Report Date : 15 Sep 2017


Pagination or Media Count : 2


Abstract : Herpes Simples Virus (HSV) is an etiologic agent of serious central nervous system (CNS) infections in both adults and children. HSV encephalitis has a worldwide incidence of about 500,000 persons per year with an overall mortality rate of 11-19 percent with treatment. Maternal HSV infection may result in neonatal disease, to include disseminated skin eye and mucous membrane (SEM) and CNS infection. Neonatal HSV infections occur approximately in 1 in 3000 to 20,000 lives births with 1500 cases reported annually with 29% mortality with aggressive treatment.


Descriptors :   ENCEPHALITIS , Herpes simplex virus , COST EFFECTIVENESS , HOSPITALIZATIONS , COST ANALYSIS , DRUG THERAPY , INFANTS , PEDIATRICS , DELIVERY OF HEALTH CARE


Subject Categories : Medicine and Medical Research
      Microbiology


Distribution Statement : APPROVED FOR PUBLIC RELEASE